NEW DELHI: Gland Pharma Ltd has set the price band for its initial public offering at ₹1,490-1,500 per share. Of these, up to 19.4 million will be sold by Fosun Pharma, while 10,047,435 shares will be sold by Gland Celsus. Kotak Mahindra Capital Co. Ltd, Citigroup Global Markets India Pvt. Ltd, Haitong Securities India Pvt. Ltd and Nomura Financial Advisory and Securities (India) Pvt.

Source: Mint November 04, 2020 06:22 UTC